Additionally, it elucidates a mechanism of immune tolerance in patients with high TMB tumors: tumor cells with high TMB antigens but defective antigen presentation systems could not successfully present tumor antigens for recognition and killing by primed CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.